Logistics & Transportation

Articles

The CRDMO’s acquisition of the Baltimore plant is expected to boost its biologics presence.

Syngene Purchases First US Manufacturing Facility for $36.5M

Videos

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the internal constraints that CFOs are reporting as their biggest manufacturing obstacle, along with other hurdles they are encountering.

Navigating Internal Constraints and Uncertainty 

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, comments on the primary factors causing manufacturing bottlenecks in the space, along with how the industry can overcome them in order to scale up production.

Overcoming Bottlenecks in Personalized Medicine Manufacturing

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, offers his perspective on the state of CGTs, along with their potential for transforming medicine.

Unlocking the Potential of Cell and Gene Therapies 

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.

Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, discusses how the tariffs impact the reshoring of manufacturing services, alongside the strategies that pharma leaders can use in order to start shoring up their supply chains.

The Case for Reshoring Manufacturing to the United States

The US president delays tariffs that comply with the 2020 USMCA for one month, with reciprocal tariffs still expected to go into effect by April 2. 

Trump Delays Certain Tariffs on Canada and Mexico

The news comes amid the possibility that President Trump imposes a 25% tariff on pharmaceuticals, which could encourage manufacturers to begin reshoring their services.

Lilly to Build Four New US Manufacturing Facilities

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Laura Johnson, senior director of sales, life sciences, Loftware, comments on other concepts that are powering the company’s 2025 Supply Chain Trends Report, and how they could possibly change in 2026.

The Role of Electronic Labeling in Sustainable Practices

The company’s Mourenx plant in Southwest France aims to become an API network hub, with first supplies expected by next year. 

Manufacturing & Packaging